Perspective Therapeutics

Perspective Therapeutics company information, Employees & Contact Information

Explore related pages

Perspective Therapeutics email format Perspective Therapeutics management contacts

Related company profiles:

We develop game-changing therapies that make an impactful difference for cancer patients and the clinicians who treat them.

Company Details

Employees
135
Founded
-
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
https://perspectivetherapeutics.com
Keywords
Oncology, Cancer Treatment, Radiopharmaceuticals, Imaging Technologies & Diagnostics.
Competitors
Clarity Pharmaceuticals, Ratio Therapeutics, Convergent Therapeutics, Inc., Telix Pharmaceuticals Limited, AdvanCell, Viewpoint Molecular Targeting, Inc., Lantheus, Nucleus RadioPharma, Fusion Pharmaceuticals, Curium Pharma.
Looking for a particular Perspective Therapeutics employee's phone or email?

Perspective Therapeutics Questions

News

Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2025 Financial Results - GlobeNewswire

Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2025 Financial Results GlobeNewswire

Perspective Therapeutics Reports 44% ORR in Cohort 2 | CATX Stock News - Stock Titan

Perspective Therapeutics Reports 44% ORR in Cohort 2 | CATX Stock News Stock Titan

Perspective Therapeutics, Inc. to Announce Q1 2025 Financial Results and Business Update on May 12, 2025 - Nasdaq

Perspective Therapeutics, Inc. to Announce Q1 2025 Financial Results and Business Update on May 12, 2025 Nasdaq

Perspective Therapeutics Appoints Biotech Veteran Joel Sendek as Chief Financial Officer - Yahoo Finance

Perspective Therapeutics Appoints Biotech Veteran Joel Sendek as Chief Financial Officer Yahoo Finance

Cancer Treatment Innovator Perspective Therapeutics to Present at Major Healthcare Conferences in NYC - Stock Titan

Cancer Treatment Innovator Perspective Therapeutics to Present at Major Healthcare Conferences in NYC Stock Titan

Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the ESMO Congress 2025 - Yahoo Finance

Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the ESMO Congress 2025 Yahoo Finance

GSK US Commercial President Maya Martinez-Davis Joins Perspective Therapeutics' Board of Directors - Stock Titan

GSK US Commercial President Maya Martinez-Davis Joins Perspective Therapeutics' Board of Directors Stock Titan

Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2025 Results - Yahoo Finance

Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2025 Results Yahoo Finance

Cancer Treatment Pioneer Perspective Therapeutics Announces Q2 2025 Earnings Date: Key Updates Coming - Stock Titan

Cancer Treatment Pioneer Perspective Therapeutics Announces Q2 2025 Earnings Date: Key Updates Coming Stock Titan

Perspective Therapeutics Announces First Patient Dosed with - GlobeNewswire

Perspective Therapeutics Announces First Patient Dosed with GlobeNewswire

Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting - Yahoo Finance

Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting Yahoo Finance

Former Wall Street All-Star Who Raised $2.5B: Perspective Therapeutics Lands Biotech Finance Veteran as CFO - Stock Titan

Former Wall Street All-Star Who Raised $2.5B: Perspective Therapeutics Lands Biotech Finance Veteran as CFO Stock Titan

Cancer Drug Developer Perspective Sees Treatment Success: 4 of 7 Patients Respond in Phase 1/2a Trial - Stock Titan

Cancer Drug Developer Perspective Sees Treatment Success: 4 of 7 Patients Respond in Phase 1/2a Trial Stock Titan

Major Breakthrough: Phase 2 NET Cancer Treatment Shows Mature Safety Data in 44 Patients, ESMO Preview - Stock Titan

Major Breakthrough: Phase 2 NET Cancer Treatment Shows Mature Safety Data in 44 Patients, ESMO Preview Stock Titan

Perspective Therapeutics Progresses Dose Finding for [212Pb]VMT01 in Combination with Nivolumab in its Ongoing Phase 1/2a Study of MC1R-Positive Metastatic Melanoma - GlobeNewswire

Perspective Therapeutics Progresses Dose Finding for [212Pb]VMT01 in Combination with Nivolumab in its Ongoing Phase 1/2a Study of MC1R-Positive Metastatic Melanoma GlobeNewswire

Perspective Therapeutics, Inc. Announces Acceptance of Updated Data for [212Pb]VMT-α-NET Program at ESMO Congress 2025 - Nasdaq

Perspective Therapeutics, Inc. Announces Acceptance of Updated Data for [212Pb]VMT-α-NET Program at ESMO Congress 2025 Nasdaq

Perspective Therapeutics, Inc. Announces Clinical Updates and Recruitment Progress for Novel Radiopharmaceuticals Ahead of 2025 ASCO Meeting - Nasdaq

Perspective Therapeutics, Inc. Announces Clinical Updates and Recruitment Progress for Novel Radiopharmaceuticals Ahead of 2025 ASCO Meeting Nasdaq

Perspective Therapeutics Highlights Updated Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET at the 2025 ASCO Annual Meeting - GlobeNewswire

Perspective Therapeutics Highlights Updated Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET at the 2025 ASCO Annual Meeting GlobeNewswire

Perspective Therapeutics Commences Recruitment for [212Pb]VMT-α-NET in the Third Dose Escalation Cohort of its Ongoing Phase 1/2a Clinical Trial - GlobeNewswire

Perspective Therapeutics Commences Recruitment for [212Pb]VMT-α-NET in the Third Dose Escalation Cohort of its Ongoing Phase 1/2a Clinical Trial GlobeNewswire

Cancer Trial Milestone: Perspective's PSV359 Advances to Higher Dose for FAP-α Positive Tumor Treatment - Stock Titan

Cancer Trial Milestone: Perspective's PSV359 Advances to Higher Dose for FAP-α Positive Tumor Treatment Stock Titan

GT Medical Technologies, Inc. Agrees to Acquire Radioactive Seed Assets from Perspective Therapeutics, Inc. - PR Newswire

GT Medical Technologies, Inc. Agrees to Acquire Radioactive Seed Assets from Perspective Therapeutics, Inc. PR Newswire

GT Medical Technologies, Inc. Completes Strategic Acquisition of Radioactive Seed Assets from Perspective Therapeutics, Inc. - PR Newswire

GT Medical Technologies, Inc. Completes Strategic Acquisition of Radioactive Seed Assets from Perspective Therapeutics, Inc. PR Newswire

Perspective Therapeutics and PharmaLogic announce collaboration for the development and production of theranostics for cancer care - PR Newswire

Perspective Therapeutics and PharmaLogic announce collaboration for the development and production of theranostics for cancer care PR Newswire

Perspective Therapeutics Announces Exclusive License Agreement with Mayo Clinic for New Radiopharmaceutical Platform for Prostate Cancer Treatment - Imaging Technology News

Perspective Therapeutics Announces Exclusive License Agreement with Mayo Clinic for New Radiopharmaceutical Platform for Prostate Cancer Treatment Imaging Technology News

CATX - Perspective Therapeutics Inc Latest Stock News & Market Updates - Stock Titan

CATX - Perspective Therapeutics Inc Latest Stock News & Market Updates Stock Titan

Companies like Perspective Therapeutics

Convergent Therapeutics, Inc. logo - Similar company to Perspective Therapeutics

Convergent Therapeut...

26
Viewpoint Molecular Targeting, Inc. logo - Similar company to Perspective Therapeutics

Viewpoint Molecular ...

5
Clarity Pharmaceuticals logo - Similar company to Perspective Therapeutics

Clarity Pharmaceuticals

65
AdvanCell logo - Similar company to Perspective Therapeutics

Advancell

65
Ratio Therapeutics logo - Similar company to Perspective Therapeutics

Ratio Therapeutics

64
Telix Pharmaceuticals Limited logo - Similar company to Perspective Therapeutics

Telix Pharmaceutical...

601
Curium Pharma logo - Similar company to Perspective Therapeutics

Curium Pharma

1.83K
Fusion Pharmaceuticals logo - Similar company to Perspective Therapeutics

Fusion Pharmaceuticals

149
Lantheus logo - Similar company to Perspective Therapeutics

Lantheus

1.22K
Nucleus RadioPharma logo - Similar company to Perspective Therapeutics

Nucleus Radiopharma

40

Top Perspective Therapeutics Employees

  • Haresh Radadiya

    Haresh Radadiya

    n/a

    Somerset, New Jersey, United States, United States
    2
    yahoo.com, novellabs.net

    1 +184856XXXXX

  • Randy Gilbert

    Randy Gilbert

    n/a

    Rock Hall, Maryland, United States, United States
    9
    gmail.com, axcellatx.com, neogene.com, broadinstitute.org, takeda.com, la-z-boy.com, aerotek.com, rhythmtx.com, sanofi.com
  • Mark Rutenburg

    Mark Rutenburg

    Vice President, Information Technology

    Framingham, Massachusetts, United States, United States
    5
    gmail.com, ironwoodpharma.com, hotmail.com, impelpharma.com, impelnp.com

    4 +161795XXXXX

  • John Grant

    John Grant

    n/a

    Cambridge, Massachusetts, United States, United States
    4
    gmail.com, intelliatx.com, intelliatx.com, albireopharma.com

    4 +185770XXXXX

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant